The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,284
Sort by:
Pharmaceutical Fine Chemicals Market Report by Type (Proprietary, Non-proprietary), Product (Active Ingredients, Basic Building Blocks, Advanced Intermediates), Size (Big Molecules, Small Molecules), Application (Cardiovascular, Neurological, Oncological, Respiratory, Gastrointestinal, Musculoskeletal, and Others), and Region 2026-2034
US$ 3,999.00
The global pharmaceutical fine chemicals market size reached USD 157.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 250.6 Billion by 2034, exhibiting a growth rate (CA...
June 2026
143 pages
Global GP681 Supply, Demand and Key Producers, 2026-2032
US$ 4,480.00
The global GP681 market size is expected to reach $ 195 million by 2032, rising at a market growth of 7.9% CAGR during the forecast period (2026-2032). GP681 is a novel oral antiviral drug targeting i...
June 2026
92 pages
Global IMP4279 Supply, Demand and Key Producers, 2026-2032
US$ 4,480.00
The global IMP4279 market size is expected to reach $ 50.90 million by 2032, rising at a market growth of 8.7% CAGR during the forecast period (2026-2032). IMP4279 is a novel DNA damage response pathw...
June 2026
93 pages
Global SHR0302 Supply, Demand and Key Producers, 2026-2032
US$ 4,480.00
The global SHR0302 market size is expected to reach $ 1234 million by 2032, rising at a market growth of 16.9% CAGR during the forecast period (2026-2032). SHR0302 (generic name: Ivarmacitinib) is a h...
June 2026
88 pages
Venom Based Drugs Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Animal Type (Snake, Spider, Bee, Others), By Source (Whole Venom, Synthetic, Recombinant, Others), By Therapeutics Area (Hypertension, Cardiovascular Diseases, Neurological Disorders, Pain Management & Arthritis, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Venom Based Drugs Market will grow from USD 1.19 Billion in 2025 to USD 1.72 Billion by 2031 at a 6.33% CAGR. The global market for venom-based drugs centers on therapeutic agents derived f...
May 2026
180 pages
Penicillin Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product (Bulk, Dosage), By Type (Aminopenicillin, Antipseudomonal Penicillin, Beta Lactamase Inhibitor, Others), By Route of Administration (Oral, Intramuscular, Intravenous), By End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Academic & Research Institutions), By Region & Competition, 2021-2031F
US$ 4,500.00
The global penicillin market is projected to expand from USD 10.43 Billion in 2025 to USD 13.21 Billion by 2031, demonstrating a compound annual growth rate (CAGR) of 4.02%. Penicillin, a group of bet...
May 2026
188 pages
Medical Cannabis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Buds/Marijuana Flower, Cannabis Extracts), By Active Ingredient (Tetrahydrocannabinol (THC), Cannabidiol (CBD), Others), By Distribution Channel (B2B, B2C), By Application (Chronic Pain, Mental Disorders, Cancer, Epilepsy, Others), By End User Industry (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Medical Cannabis Market is anticipated to experience substantial growth, expanding from USD 28.81 Billion in 2025 to USD 90.82 Billion by 2031 at a CAGR of 21.09%. This market involves the...
May 2026
180 pages
Muscle Relaxant Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type (Skeletal Muscle Relaxant Drugs, Facial Muscle Relaxant Drugs, Neuromuscular Blocking Agents), By Route of Administration (Oral, Injectable, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The global muscle relaxant drugs market is projected to expand from USD 4.15 Billion in 2025 to USD 5.38 Billion by 2031, exhibiting a 4.42% Compound Annual Growth Rate. These pharmaceutical agents ar...
May 2026
182 pages
Haemophilia Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Haemophilia A, Haemophilia B, Haemophilia C), By Product (Recombinant Coagulation Factor Concentrates, Plasma Derived Coagulation Factor Concentrate, Desmopressin, Antifibrinolytics Agents), By Treatment (On-demand and Prophylaxis), By Therapy (Replacement Therapy, ITI therapy and Gene Therapy), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Haemophilia Treatment Market is projected to expand from USD 12.03 Billion in 2025 to USD 16.82 Billion by 2031, registering a CAGR of 5.75%. Treatment methodologies include replacement the...
May 2026
180 pages
Addison’s Disease Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Primary Adrenal Insufficiency, Secondary Adrenal Insufficiency, Tertiary Adrenal Insufficiency), By Drug Class (Oral Corticosteroid, Corticosteroid Injections, Sodium Intake), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Addison's Disease Market is anticipated to grow from USD 546.23 Million in 2025 to USD 809.68 Million by 2031, achieving a Compound Annual Growth Rate (CAGR) of 6.78%. This market primarily...
May 2026
180 pages
Andersen-Tawil Syndrome Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Disease Type (Type 1, Type 2), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The global market for Andersen-Tawil Syndrome is projected to expand from USD 2.78 billion in 2025 to USD 4.25 billion by 2031, demonstrating a compound annual growth rate of 7.33%. This market primar...
May 2026
182 pages
Ankylosing Spondylitis Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug (Cosentyx, Humira, Simponi, Remicade, Enbrel, Cimzia), By End Use (Hospitals, Clinics, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The global market for Ankylosing Spondylitis therapeutics is projected to expand significantly, rising from USD 7.88 Billion in 2025 to USD 11.27 Billion by 2031, at a Compound Annual Growth Rate of 6...
May 2026
182 pages
Hemophilia A Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment Type (Factor Replacement Therapy, Non-Factor Replacement Therapies, Gene Therapy), By Route of Administration (Intravenous, Oral, Nasal), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Hemophilia A Treatment Market is projected for significant growth, expanding from USD 14.73 Billion in 2025 to USD 21.44 Billion by 2031, representing a Compound Annual Growth Rate (CAGR) o...
May 2026
185 pages
Hyperuricemia Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Primary, Secondary), By Drug Type (Xanthine Oxidase Inhibitors, Nonsteroidal Anti-Inflammatory Drugs, Corticosteroids, Others), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The global hyperuricemia market, which includes urate-lowering therapeutics and diagnostic tools for managing elevated serum uric acid, is projected to expand from USD 4.78 billion in 2025 to USD 7.13...
May 2026
185 pages
Iron Deficiency Anemia Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapy Type (Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion, Others), By Therapy Areas (Obstetrics and Gynecology, Oncology, Congestive Heart Failure (CHF), Inflammatory Bowel Disease, Renal, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Iron Deficiency Anemia Market, comprising therapeutic solutions like oral and parenteral iron formulations aimed at replenishing iron stores and normalizing hemoglobin levels, is projected...
May 2026
180 pages
Opioid Use Disorder Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type (Agonist Drugs, Antagonist Drugs, Others), By Route of Administration (Oral, Parenteral, Sublingual, Nasal), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Opioid Use Disorder (OUD) Drugs Market is projected to expand robustly from USD 3.89 Billion in 2025 to USD 6.81 Billion by 2031, at a Compound Annual Growth Rate of 9.78%. This market enco...
May 2026
180 pages
Rheumatology Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Indication (Ankylosing Spondylitis, Gout, Osteoarthritis, Psoriatic Arthritis, Rheumatoid Arthritis), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Rheumatology Therapeutics Market is projected to expand from USD 49.68 Billion in 2025 to USD 58.19 Billion by 2031, demonstrating a compound annual growth rate (CAGR) of 2.67%. This market...
May 2026
182 pages
Rosai-Dorfman Disease Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Classic (nodal) Rosai-Dorfman disease, Extranodal Rosai-Dorfman disease), By Procedure Type (Diagnosis, Treatment), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The global Rosai-Dorfman Disease (RDD) market is projected to expand from USD 533.12 billion in 2025 to USD 772.22 billion by 2031, exhibiting a compound annual growth rate (CAGR) of 6.37%. RDD is a r...
May 2026
182 pages
Systemic Juvenile Idiopathic Arthritis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment Type (Drug Treatment {Anti-inflammatories (NSAIDS), Tumor Necrosis Factor (TNF) Blockers, Muscle Relaxants, Immune Suppressants Drugs, Disease Modifying Antirheumatic Drugs, Others}, Biologics, Other), By Route of Administration (Oral, Injectables, Other), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Systemic Juvenile Idiopathic Arthritis Market is projected to expand from USD 1.93 Billion in 2025 to USD 2.31 Billion by 2031, reflecting a Compound Annual Growth Rate (CAGR) of 3.04%. Sys...
May 2026
185 pages
Xerostomia Therapeutics Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Type (OTC, Prescription), By Product (Salivary Stimulants, Salivary Substitutes, Dentifrices), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Xerostomia Therapeutics Market is projected to expand from USD 2.74 Billion in 2025 to USD 3.47 Billion by 2031, exhibiting a Compound Annual Growth Rate (CAGR) of 4.02%. These therapeutics...
May 2026
192 pages
Acquired Orphan Blood Diseases Therapeutics Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapy (Recombinant Factor, Immunoglobulin Infusion Therapy, Activated Prothrombin Complex Concentrate, Thrombopoietin Receptor Agonists, Others), By Disease Indication (Acquired Agranulocytosis, Acquired Hemophilia, Acquired Von Willebrand Syndrome, Paroxysmal Nocturnal Hemoglobinuria (PNH), Myelodysplastic Syndrome, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The global market for therapeutics targeting acquired orphan blood diseases is projected to expand significantly, from USD 8.13 billion in 2025 to USD 12.82 billion by 2031, demonstrating a compound a...
May 2026
182 pages
Bulk Drug Market – Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Type (Antibiotics, Sulpha Drugs, Vitamins, Steroids, Analgesics, Others), By End-User (Pharmaceuticals, Biotechnology, Veterinary Medicine), By Region & Competition, 2021-2031F
US$ 4,500.00
The global bulk drug market, encompassing Active Pharmaceutical Ingredients (APIs), is projected for substantial growth, expanding from USD 465.12 billion in 2025 to USD 925.96 billion by 2031 with a...
May 2026
182 pages
Chronic Pain Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Indication (Neuropathic Pain, Analgesic Infusion, Ablation), By Product Type (Drugs, Devices), By Distribution Channel (Hospital & Clinics, Ambulatory Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Chronic Pain Treatment Market is projected to expand significantly, rising from USD 86.23 Billion in 2025 to USD 136.53 Billion by 2031, demonstrating a Compound Annual Growth Rate (CAGR) o...
May 2026
180 pages
